Evidence map›Paper›PMID 20585572›Full record

ArticlePLoS pathogens2010

Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Yumi Nakayama, Erin H Plisch, Jeremy Sullivan, Chester Thomas, Charles J Czuprynski, Bryan R G Williams, M Suresh

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Pre-Encoded IFN-I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yumi NakayamaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Erin H Plisch
Jeremy Sullivan
Chester Thomas
Charles J Czuprynski
Bryan R G Williams
M Suresh
University of Wisconsin–Madison · USMonash Institute of Medical Research · AU

Funding

Regulation of CD8 T Cell Immunity by TNF ReceptorsR01AI048785 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2002 to 2012
$3.3M
Direct Regulation of CD8 T Cells by Interferon gammaR01AI059804 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2004 to 2010
$1.4M
Enhancement of CD8 T Cell Immunity by IL-7 TherapyR21AI068841 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2007 to 2008
$393k
REGULATION OF CD8 T CELL IMMUNITY BY TNF RECEPTORSR21AI048785 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI SURESH, MARULASIDDAPPA · 2001 to 2001
$291k
NIAID NIH HHS AI048785NIAID NIH HHS AI059804NIAID NIH HHS AI068841NIAID NIH HHS R01 AI048785NIAID NIH HHS R01 AI059804NIAID NIH HHS R21 AI048785NIAID NIH HHS R21 AI068841
6 · The paper itself

Abstract

Type I interferons (IFNs) are known to mediate viral control, and also promote survival and expansion of virus-specific CD8+ T cells. However, it is unclear whether signaling cascades involved in eliciting these diverse cellular effects are also distinct. One of the best-characterized anti-viral signaling mechanisms of Type I IFNs is mediated by the IFN-inducible dsRNA activated protein kinase, PKR. Here, we have investigated the role of PKR and Type I IFNs in regulating viral clearance and CD8+ T cell response during primary and secondary viral infections. Our studies demonstrate differential requirement for PKR, in viral control versus elicitation of CD8+ T cell responses during primary infection of mice with lymphocytic choriomeningitis virus (LCMV). PKR-deficient mice mounted potent CD8+ T cell responses, but failed to effectively control LCMV. The compromised LCMV control in the absence of PKR was multifactorial, and linked to less effective CD8+ T cell-mediated viral suppression, enhanced viral replication in cells, and lower steady state expression levels of IFN-responsive genes. Moreover, we show that despite normal expansion of memory CD8+ T cells and differentiation into effectors during a secondary response, effective clearance of LCMV but not vaccinia virus required PKR activity in infected cells. In the absence of Type I IFN signaling, secondary effector CD8+ T cells were ineffective in controlling both LCMV and vaccinia virus replication in vivo. These findings provide insight into cellular pathways of Type I IFN actions, and highlight the under-appreciated importance of innate immune mechanisms of viral control during secondary infections, despite the accelerated responses of memory CD8+ T cells. Additionally, the results presented here have furthered our understanding of the immune correlates of anti-viral protective immunity, which have implications in the rational design of vaccines.

Indexed as

AnimalsBlotting, WesternCD8-Positive T-LymphocyteseIF-2 KinaseEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryFluorescent Antibody TechniqueHomeodomain ProteinsImmunologic MemoryInterferon Type IListeria monocytogenesListeriosisLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleeIF-2 KinaseHomeodomain ProteinsInterferon Type IRAG-1 proteinRNA, Messenger

Identifiers

PMID20585572
PMCPMC2891951
OpenAlexW2045423123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.